Petco Health & Wellness Company, Inc. - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for Petco Health & Wellness Company, Inc. (Petco), a pet specialty retailer operating over 1,500 pet care centers in the U.S., Mexico, and Puerto Rico. The report covers the thirteen and twenty-six weeks ended August 2, 2025. Petco operates as a single reportable segment, focusing on an omnichannel ecosystem of products and services.
Key Financial Metrics
| Metric | 13 Weeks Ended Aug 2, 2025 | 26 Weeks Ended Aug 2, 2025 |
|---|---|---|
| Net Sales | $1.49 billion | $2.98 billion |
| Gross Profit | $585.3 million (39.3% margin) | $1.16 billion (38.7% margin) |
| Operating Income | $43.0 million (2.9% margin) | $59.4 million (1.9% margin) |
| Net Income (Attributable to Common Stockholders) | $14.0 million | $2.3 million |
| Adjusted EBITDA | $113.9 million (7.6% margin) | $203.3 million (6.8% margin) |
| Free Cash Flow (26 weeks) | $9.9 million | |
| Cash and Cash Equivalents | $188.7 million (as of Aug 2, 2025) | |
| Total Debt (Term Loan) | $1.595 billion outstanding | |
| Liquidity (Cash + ABL Availability) | $683.9 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 2.3% year-over-year (YoY) for both the 13-week and 26-week periods. Comparable sales declined 1.4% for the quarter and 1.3% for the year-to-date. The decrease was driven by lower transaction volume, a reduced pet care center count (1,388 vs. 1,420 last year), and a strategic shift toward profitability over volume.
- Profitability Improvement: Despite lower sales, Operating Income improved significantly from $2.5 million to $43.0 million for the quarter. Net Income turned positive at $14.0 million, compared to a net loss of $24.8 million in the prior year quarter.
- Margin Expansion: Gross profit margin expanded to 39.3% from 38.1% YoY, attributed to better inventory management, unit cost control, and improved utilization of the services footprint. SG&A expenses decreased as a percentage of sales (36.4% vs. 37.9%) due to lower payroll and consulting costs.
- Interest Expense: Interest expense decreased 9.5% YoY to $33.3 million for the quarter, primarily due to lower interest rates on the First Lien Term Loan.
Guidance, Outlook, and Risks
Management Commentary: Management emphasizes a disciplined approach to managing unit costs, pricing, and promotional strategies to drive profitability. Momentum in the services segment continues, supported by strategic investments in customer acquisition and optimization of the veterinary hospital footprint. The company expects to continue improving comparable sales through initiatives targeting customer retention and basket size.
Tax Legislation: The "One Big Beautiful Bill Act" (OBBBA) was signed into law on July 4, 2025. It introduced 100% bonus depreciation and immediate expensing of domestic R&D. While this reduced current income tax expense, it was offset by an increase in deferred tax expense, resulting in no material net impact on the effective tax rate for the period.
Risks and Contingencies:
- Macroeconomic Factors: Inflation, interest rates, tariffs, and geopolitical developments remain key risks.
- Competition: Increased competition from multi-channel, mass, and grocery retailers.
- Supply Chain: Potential disruptions and constraints.
- Legal: The company is involved in ordinary course litigation but does not expect a material adverse effect on financial statements.
Investor Verification Checklist
- Store Count Reduction: Verify the strategic rationale and long-term impact of closing pet care centers (down to 1,388 from 1,420) on future revenue growth.
- Services Growth: Assess the sustainability of the 1.1% growth in services revenue amidst broader product sales declines.
- Debt Servicing: Monitor the $1.595 billion term loan balance and the impact of variable interest rates on future cash flows, despite recent rate decreases.
- Inventory Management: Review the $44.8 million reduction in inventory (cash flow statement) to ensure it aligns with sales trends and does not indicate stockouts.
- Non-GAAP Reconciliations: Scrutinize the Adjusted EBITDA reconciliation, specifically the $20.6 million contribution from the Mexico joint venture and the $6.0 million in "Other costs" excluded from the metric.